Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aan
    Member
    • Mar 2012
    • 14

    #1

    Trend of Ti/Tv ratio in different tranches in VQSR tranche file?

    Hi all

    I am running VQSR for exome data and as a result of its first step i.e recalibration and calculation of VQSLOD, it also gives a tranche file which contains Ti/Tv ratios as one of the parameters along with others.
    As per my knowledge the Ti/Tv ratio should be around 2.3 for exome data and it should decrease as the tranche size increases (from 90 to 99.-100). But in my case the trend of this ratio is reverse for novel variants (its fine for known variants) and is as follows:


    targetTruthSensitivity numKnown numNovel knownTiTv novelTiTv minVQSLod filterName accessibleTruthSites callsAtTruthSites truthSensitivity
    90 82669 3570 2.3897 0.9188 5.703 TruthSensitivityTranche0.00to90.00 39003 35102 0.9
    99 95796 4084 2.3625 1.0044 2.3102 TruthSensitivityTranche90.00to99.00 39003 38612 0.99
    99.9 106287 6236 2.3037 1.0132 -4.2613 TruthSensitivityTranche99.00to99.90 39003 38963 0.999
    100 111724 9022 2.2558 1.1301 -37928.8734 TruthSensitivityTranche99.90to100.00 39003 39003 1


    Is this a worry or it is supposed to be so. If yes then why?

    Thanks in advance.
  • Heisman
    Senior Member
    • Dec 2010
    • 534

    #2
    Why do you think it should be around 2.3 for exomic variants? http://www.broadinstitute.org/gsa/wi...php/QC_Methods indicates it should be closer to 3.3 and novel variants should be closer to 2.8-3.0.

    Comment

    • aan
      Member
      • Mar 2012
      • 14

      #3
      Thanks for the updated information, I acquired this information from one of the posts on Biostar.

      Then looking at my data (statistics of tranche file that I posted) I seems that there are a lot of false positives!! Is that right?

      If yes, then is there any way out to further refine the data?

      Thanks.

      Comment

      • Heisman
        Senior Member
        • Dec 2010
        • 534

        #4
        It does imply you have a lot of false positives, if you are sure you are looking only at coding variants. Can you take a subset of SNPs with high coverage and high quality scores and see what the Ti/Tv ratio is there?

        Comment

        • aan
          Member
          • Mar 2012
          • 14

          #5
          What if I only include SNPs with PASS status for further analysis and ignore rest that fall in even highest tranches?

          Comment

          • aan
            Member
            • Mar 2012
            • 14

            #6
            Another query that I have is, why is it that Ti/Tv ratio decreases in case of known variants as we move from 90 to 100 tranche (as expected) whereas the trend is opposite in case of novel variants?

            I understand that low value for this ratio indicates high FPs but what does increase in Ti/Tv ratio indicates? same thing or sth else?

            Comment

            • Heisman
              Senior Member
              • Dec 2010
              • 534

              #7
              I've only ever used SAMtools to call SNPs so I'm not sure what the various values and tranches refer to, so I can't be too helpful there. I'm not sure how to interpret this. The reason I suggested taking your best quality SNPs and checking the ratio there is because that should give an indication of what values you should see for the entire data set.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                by SEQadmin2



                Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                ...
                10-14-2026, 09:55 AM
              • SEQadmin2
                New Genomics Technologies Take Aim at Long-Standing Limits
                by SEQadmin2


                Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                ...
                09-28-2026, 10:25 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 10-22-2026, 11:13 AM
              0 responses
              42 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-22-2026, 10:48 AM
              0 responses
              32 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-15-2026, 10:52 AM
              0 responses
              44 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-14-2026, 05:39 AM
              0 responses
              45 views
              0 reactions
              Last Post SEQadmin2  
              Working...